Sophie Lawrance specializes in EU and UK competition law. She has a particular interest in working with businesses in technology and pharmaceutical sectors, and in relation to the competition issues that arise in connection with standardized technology. Sophie has a strong behavioral practice, advising on issues spanning access to technology, duties to supply and pricing issues, as well as in relation to issues arising out of complex vertical and horizontal agreements.
Sophie has significant experience of competition litigation in the UK courts. She has been involved both in pure competition law actions and in several substantial pieces of patent litigation in which competition defenses have been raised (acting both for claimants and defendants). Her case load to date has included defending applications for interim injunctive relief, mixed stand-alone/follow-on damages claims, competition issues arising from second medical use patent claims, and a number of cases involving standard essential patents and FRAND.
Sophie has also advised in the context of numerous cases before competition regulators at EU and national level, including in dawn raid situations. Issues on which she has advised in this context include both substantive competition law and procedural issues, such as legal professional privilege.
Sophie was elected in 2017 to become a member of the Competition Law Association (CLA) Committee and has previously participated in a number of working groups involved in commenting on or developing UK and EU law/guidance. She speaks regularly at conferences (e.g. IBC Competition Law in the Pharmaceutical Sector; IBC Standards and Patents) and writes extensively on competition law issues in books, journals and blogs, in particular concerning the interface with IP law. Sophie is a regular contributor to Bristows blog on the competition/IP interface, the CLIP Board.